Glenmark Pharma arm files papers for IPO
PTI
New Delhi |
Updated on
April 17, 2021
×
Glenmark Life Sciences Ltd to make fresh issue of up to ₹1,160 crore and OFS of up to 73,05,245 equity shares of ₹2 each
Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer (IPO) with market regulator SEBI. Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, said a regulatory filing. The offer comprises a fresh issue of up to ₹1,160 crore and an offer-for-sale (OFS) of up to 73,05,245 equity shares of ₹2 each of Glenmark Life Sciences Ltd, by Glenmark Pharmaceuticals Ltd, the filing said.